Location History:
- Rockville, MD (US) (2013)
- Potomac, MD (US) (2012 - 2024)
Company Filing History:
Years Active: 2012-2025
Title: The Innovative Contributions of Zhiya Yu
Introduction
Zhiya Yu is a prominent inventor based in Potomac, MD (US), known for her significant contributions to the field of cancer research. With a total of 10 patents, her work focuses on developing advanced T cell receptors that target specific cancer-related antigens.
Latest Patents
Among her latest patents is the development of anti-mutated KRAS T cell receptors. This invention discloses an isolated or purified T cell receptor (TCR) that has antigenic specificity for an HLA-A11-restricted epitope of mutated Kirsten rat sarcoma viral oncogene homolog (KRAS), Neuroblastoma RAS Viral (V-Ras) Oncogene Homolog (NRAS), or Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS). The patent also includes related polypeptides, proteins, nucleic acids, recombinant expression vectors, host cells, and pharmaceutical compositions. Additionally, methods for detecting the presence of cancer in mammals and methods for treating or preventing cancer are also disclosed. Another notable patent is for anti-thyroglobulin T cell receptors, which describes a synthetic T cell receptor (TCR) with antigenic specificity for an HLA-A2-restricted epitope of thyroglobulin (TG). This patent also encompasses related polypeptides, proteins, nucleic acids, and pharmaceutical compositions, along with methods for cancer detection and treatment.
Career Highlights
Zhiya Yu is currently affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to make groundbreaking advancements in cancer immunotherapy.
Collaborations
Throughout her career, Zhiya has collaborated with notable colleagues, including Qiong J Wang and James C Yang. These collaborations have further enhanced her research and contributed to the development of innovative cancer treatments.
Conclusion
Zhiya Yu's contributions to cancer research through her innovative patents and work at the National Institutes of Health highlight her as a leading figure in the field. Her dedication to advancing cancer treatment continues to inspire and pave the way for future innovations.